Tumor necrosis factor receptor modulator spermatogenesis‐associated protein 2 is a novel predictor of outcome in ovarian cancer

por Wieser, Verena, Tsibulak, Irina, Degasper, Christine, Welponer, Hannah, Leitner, Katharina, Parson, Walther, Zeimet, Alain G., Marth, Christian, Fiegl, Heidelinde
Publicado 2019

BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer

por Tsibulak, Irina, Wieser, Verena, Degasper, Christine, Shivalingaiah, Giridhar, Wenzel, Sören, Sprung, Susanne, Lax, Sigurd F., Marth, Christian, Fiegl, Heidelinde, Zeimet, Alain G.
Publicado 2018

The miR-34 family and its clinical significance in ovarian cancer

por Welponer, Hannah, Tsibulak, Irina, Wieser, Verena, Degasper, Christine, Shivalingaiah, Giridhar, Wenzel, Sören, Sprung, Susanne, Marth, Christian, Hackl, Hubert, Fiegl, Heidelinde, Zeimet, Alain G.
Publicado 2020